RPS6KA1
RPS6KA1 (ribosomal protein S6 kinase A1) is a member of the RSK family of serine/threonine kinases, also known as RSK1, p90Rsk, HU-1 and MAPKAPK1. It phosphorylates a range of substrates, including components of the MAPK signalling pathway, and has been implicated in the control of cell growth and differentiation. Browse Assay Genie's current range of RPS6KA1 research reagents below, or read on for the biology behind the target.
RPS6KA1 encodes a serine/threonine kinase of the RSK (ribosomal S6 kinase) family. The protein contains two nonidentical kinase catalytic domains and phosphorylates various substrates, among them members of the mitogen-activated protein kinase (MAPK) signalling pathway. Its activity has been implicated in controlling cell growth and differentiation, which makes the RPS6KA1 protein a frequent subject in studies of MAPK-driven signalling.
The kinase belongs to the protein kinase superfamily, in the AGC Ser/Thr protein kinase family and the S6 kinase subfamily. It is annotated to the nucleus and the cytoplasm. The RPS6KA1 gene produces alternative transcriptional splice variants that encode different isoforms. HGNC places it in the groups of MAPK activated protein kinases, the ribosomal protein S6 kinase family, and microRNA protein coding host genes.
The gene has carried several names. Alongside RPS6KA1, the literature uses RSK1, p90Rsk, HU-1 and MAPKAPK1, and the earlier HGNC name was ribosomal protein S6 kinase, 90kD, polypeptide 1. In the context of infection, UniProt notes that when constitutively activated, the kinase promotes late transcription and translation of viral lytic genes during Kaposi's sarcoma-associated herpesvirus (HHV-8) infection. Mouse and rat each have an orthologous gene named Rps6ka1.
RPS6KA1 phosphorylates substrates including members of the MAPK signalling pathway, so it is used to study how this cascade is relayed downstream.
Kinase activity of RPS6KA1 has been implicated in controlling cell growth and differentiation, a focus of developmental and cell biology research.
As a member of the RSK family with two catalytic domains, RPS6KA1 is studied alongside related S6 kinases to compare their roles.
When constitutively activated, RPS6KA1 promotes late viral lytic gene transcription and translation in HHV-8 infection, linking it to herpesvirus biology.
RPS6KA1 is a serine/threonine kinase of the RSK family. It phosphorylates various substrates, including members of the MAPK signalling pathway, and its activity has been implicated in controlling cell growth and differentiation. It is annotated to the nucleus and cytoplasm.
RPS6KA1 is also called RSK1, p90Rsk, HU-1 and MAPKAPK1, and was formerly named ribosomal protein S6 kinase, 90kD, polypeptide 1. Alternative transcriptional splice variants have been characterised that encode different isoforms of the protein.
Mouse and rat both carry an orthologous gene, Rps6ka1. UniProt reports that, when constitutively activated, the kinase promotes late transcription and translation of viral lytic genes in Kaposi's sarcoma-associated herpesvirus (HHV-8) infection. Check the datasheet of any product for its validated reactivity.
Other RSK and S6 kinase family members and ribosomal protein targets from the same research area.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q15418; product specifications from Assay Genie datasheets.